TMU454
TMU454 is a prototype GalNAc-PROTAC conjugate. It binds to ASGPR on the cell membrane and is internalized through ASGPR-mediated endocytosis. TMU454 selectively degrades BRD4 and exhibits anticancer activity against hepatocellular carcinoma.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
